Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00535626 · ClinicalTrials.gov registry record · NA

Trident® Tritanium™ Acetabular Shell Revision Study

A NA study, sponsored by Stryker Orthopaedics.

Completed
Registry status
NA
Development phase
241
Enrollment target

NCT00535626 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 241 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00535626, a NA study, has completed, sponsored by Stryker Orthopaedics.

COMPLETED
Registry status
NA
Development phase
241 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

Interventions

  • DEVICE Trident® Tritanium™ Acetabular Shell

Trial Details

FieldValue
Enrollment Target 241 participants
Start Date 2006-11
Est. Completion 2016-09
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

What the Registry Record Tells You About NCT00535626

The ClinicalTrials.gov registry entry for NCT00535626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Trident® Tritanium™ Acetabular Shell is the first listed.

NCT00535626 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00535626 about?

NCT00535626 is a clinical study titled "Trident® Tritanium™ Acetabular Shell Revision Study". The purpose of this study is to evaluate a hip implant system used when a previous hip replacement surgery has failed.

What is the current status of trial NCT00535626?

This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2006-11. Estimated completion is 2016-09.

What interventions are being tested in trial NCT00535626?

The interventions under investigation include: Trident® Tritanium™ Acetabular Shell (DEVICE).

Who is sponsoring clinical trial NCT00535626?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.